Breast cancer survivor offers wisdom at Faulkner satellite center
Call 877-422-3324 today to make an appointment
Make your appointment or second opinion with Dana-Farber today to meet with an onsite specialist.
Can’t get to Boston? Explore our Online Second Opinion service to get expert advice from Dana-Farber oncologists.
Toll-Free Number866-408-DFCI (3324)
Discover the ways to give and how to get involved to support Dana-Farber.
Poet Richard Fox gains insight – and material – through cancer treatment
A family faces cancer in an unfamiliar city – with help
Choosing mastectomy or not: Studying young women's surgical choices
Jeff's targeted therapy has kept his advanced lung cancer at bay.
A selection of articles from the Spring/Summer 2012 issue of Paths of Progress.
Download this issue for your iPad from iTunes
Download this issue for your Android-based tablet from Google Play
To see the entire publication, please download the PDF version. If you'd like to receive a print version of Paths of Progress in the mail, please complete this form.
Soon after becoming pregnant, Rebecca is stunned to learn she has breast cancer. She turns to specialists at Dana-Farber/Brigham and Women's Cancer Center, who offer treatment options to keep both her and her baby safe.
Scientists are traditionally secretive about their work. But at Dana-Farber, Jay Bradner and colleagues are taking an open-source approach and sharing their findings with researchers worldwide. The result: the development of a potential new cancer drug.
In order to speed the pace at which new cancer drugs move from lab to clinical use, Dana-Farber's integrative research centers help scientists accelerate the discovery, evaluation, refinement, and early testing of potential treatments.
Sourcing existing patient-care information from doctors, insurance companies, and clinics, scientists are using comparative analysis research to get a big-picture view of cancer treatment effectiveness.
Scientific discovery rarely follows a straight path. These stories show how Dana-Farber's resourceful researchers take different approaches to uncovering cancer's genetic secrets.
Because childhood sarcomas are so rare, researchers collaborate internationally to share information. Doctors and scientists at Dana-Farber/Children's Hospital Cancer Center are leading clinical trials on three types of sarcoma in children.
In the search for effective treatments for rare pediatric cancers such as osteosarcoma, progress in patient care is dependent on discoveries in the lab, and relies heavily on work in academic institutions.